Breaking News Instant updates and real-time market news.

GNFT

Genfit

$16.82

1.44 (9.36%)

11:25
12/12/19
12/12
11:25
12/12/19
11:25

Roth Capital healthcare analyst to hold an analyst/industry conference call

Healthcare Analyst Rahimi along with Bart Staels, Co-Founder and Chairman of the Scientific Advisory Board at Genfit, discusses the biology underlying PPARalpha and PPARdelta agonism on an Analyst/Industry conference call to be held on December 12 at 12:30 pm.

  • 12

    Dec

  • 18

    Dec

GNFT Genfit
$16.82

1.44 (9.36%)

09/11/19
RILY
09/11/19
NO CHANGE
Target $52
RILY
Buy
Genfit risk/reward 'extremely compelling' after selloff, says B. Riley FBR
B. Riley FBR analyst Mayank Mamtani finds Genfit's risk/reward profile "extremely compelling" at current levels following the recent selloff in the shares. The analyst expects a "sentiment turnaround" ahead of the company's Phase III Resolve-It trial results in Q1 of 2020. Genfit's lead program elafibranor offers one of the "very few" development programs currently in Phase III for large patient population non-alcoholic steatohepatitis, which is "also scientifically and clinically de-risked in a meaningful way," Mamtani tells investors in a research note. He reiterates a Buy rating on Genfit shares with a $52 price target.
10/01/19
HCWC
10/01/19
NO CHANGE
Target $72
HCWC
Buy
Genfit selloff brings 'compelling' entry point, says H.C. Wainwright
H.C. Wainwright analyst Ed Arce sees a "compelling" entry point for Genfit (GNFT) with the shares down 34% since June 10. An "uninformed and unfair derivative response" to the failure of CymaBay's (CBAY) seladelpar to reduce steatosis in nonalcoholic steatohepatitis patients by week 12 has drove the weakness in Genfit shares, Arce tells investors in a research note. He points out that while seladelpar is a highly selective PPAR delta agonist, Genfit's elafibranor is a dual agonist of PPAR alpha and PPAR delta. As such, there are clear mechanistic differences between the two PPAR-targeted compounds, says the analyst. He affirms a Buy rating on Genfit with a $72 price target.
10/31/19
HCWC
10/31/19
NO CHANGE
Target $58
HCWC
Buy
Genfit price target lowered to $58 from $72 at H.C. Wainwright
H.C. Wainwright analyst Ed Arce lowered his price target for Genfit to $58 from $72 and keeps a Buy rating on the shares ahead of elafibranor's pivotal data readout from the Phase 3 RESOLVE-IT NASH trial expected in Q1 of 2020. The analyst expects the redound to settle doubts about elafibranor in nonalcoholic steatohepatitis.
11/26/19
HCWC
11/26/19
NO CHANGE
HCWC
Favorable safety a positive for Genfit's elafibranor, says H.C. Wainwright
After Genfit (GNFT) this morning announced that the Data Safety Monitoring Board issued a positive recommendation for the continuation, without any modifications, of the Resole-It Phase 3 trial evaluating elafibranor in nonalcoholic steatohepatitis, H.C. Wainwright analyst Ed Arce noted this is the seventh such report affirming the favorable safety profile of elafibranor. After CymaBay (CBAY) announced yesterday that it has halted all clinical development of its lead drug seladelpar, Arce also noted that there have been no cases of interface hepatitis seen in all trials to date with elafibranor. "One less competitor only benefits the other players in the space, and the two remaining PPARs, especially elafibranor," added Arce. Commenting further on Intercept's (ICPT) announcement yesterday that the FDA has accepted its NDA for obeticholic acid for accelerated approval for the treatment of fibrosis due to NASH, Arce said he sees "two very differentiated profiles with the first two drugs likely to be approved for NASH," namely Intercept's OCA and Genfit's elafibranor. The analyst, who concludes with the assertion that the "overall efficacy, safety and tolerability profile of elafibranor is hands down superior to that of OCA," keeps a Buy rating and $58 price target on Genfit shares.

TODAY'S FREE FLY STORIES

LLY

Eli Lilly

$140.65

1.04 (0.74%)

13:35
01/21/20
01/21
13:35
01/21/20
13:35
Hot Stocks
Eli Lilly to invest over $470M to build new manufacturing facility in Durham »

Eli Lilly will invest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 27

    Jan

  • 30

    Jan

  • 10

    Feb

BBD

Banco Bradesco

$7.99

-0.445 (-5.28%)

13:35
01/21/20
01/21
13:35
01/21/20
13:35
Options
Banco Bradesco put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

HCMLY

LafargeHolcim

$0.00

(0.00%)

13:30
01/21/20
01/21
13:30
01/21/20
13:30
Downgrade
LafargeHolcim rating change  »

LafargeHolcim downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AWI

Armstrong World

$103.07

1.07 (1.05%)

13:29
01/21/20
01/21
13:29
01/21/20
13:29
Upgrade
Armstrong World rating change  »

Armstrong World upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDRBF

Bombardier

$0.00

(0.00%)

, ALSMY

Alstom

$0.00

(0.00%)

13:25
01/21/20
01/21
13:25
01/21/20
13:25
Periodicals
Bombardier in talks to combine rail unit with Alstom, Bloomberg reports »

Bombardier (BDRBF) is…

BDRBF

Bombardier

$0.00

(0.00%)

ALSMY

Alstom

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

TSLA

Tesla

$541.60

31.26 (6.13%)

13:25
01/21/20
01/21
13:25
01/21/20
13:25
Periodicals
Tesla in settlement deal with Michigan over sales ban, Bloomberg says »

A Tesla settlement filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

  • 24

    Feb

  • 23

    Mar

  • 23

    Mar

IQ

iQIYI

$23.85

-0.06 (-0.25%)

13:25
01/21/20
01/21
13:25
01/21/20
13:25
Options
iQiyi call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

13:25
01/21/20
01/21
13:25
01/21/20
13:25
General news
U.S. corporate bond update: a heavy calendar is building »

U.S. corporate bond…

13:25
01/21/20
01/21
13:25
01/21/20
13:25
Conference/Events
Wolfe Research tech strategist to hold an analyst/industry webcast »

Tech Strategist…

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$332.09

0.08 (0.02%)

13:19
01/21/20
01/21
13:19
01/21/20
13:19
Periodicals
CDC to announce first case of Wuhan coronavirus reported in U.S., CNN says »

AnneClaire Stapleton of…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$332.09

0.08 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$336.30

-3.26 (-0.96%)

, DIS

Disney

$143.99

-0.26 (-0.18%)

13:18
01/21/20
01/21
13:18
01/21/20
13:18
On The Fly
Fly Intel: What to watch in Netflix earnings report »

Netflix (NFLX) is…

NFLX

Netflix

$336.30

-3.26 (-0.96%)

DIS

Disney

$143.99

-0.26 (-0.18%)

CMCSA

Comcast

$47.13

-0.35 (-0.74%)

T

AT&T

$38.54

0.18 (0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

  • 23

    Jan

  • 29

    Jan

  • 04

    Feb

WHR

Whirlpool

$152.18

-0.45 (-0.29%)

13:17
01/21/20
01/21
13:17
01/21/20
13:17
Periodicals
AHAM reports 'big 6' appliance shipments up 6.4% in December, Bloomberg says »

The Association of Home…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
01/21/20
01/21
13:17
01/21/20
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
01/21/20
01/21
13:16
01/21/20
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAH

Cardinal Health

$53.92

0.02 (0.04%)

13:15
01/21/20
01/21
13:15
01/21/20
13:15
Options
Cardinal Health put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 10

    Feb

JPM

JPMorgan

$137.90

-0.25 (-0.18%)

, APTX

Aptinyx

$4.97

0.39 (8.52%)

13:09
01/21/20
01/21
13:09
01/21/20
13:09
On The Fly
Fly Insider: Aptinyx, Zscaler among week's notable insider trades »

Welcome to "Fly Insider,"…

JPM

JPMorgan

$137.90

-0.25 (-0.18%)

APTX

Aptinyx

$4.97

0.39 (8.52%)

OSMT

Osmotica Pharmaceuticals

$6.41

0.55 (9.39%)

TRN

Trinity Industries

$20.31

-0.61 (-2.92%)

CMD

Cantel Medical

$65.92

3.47 (5.56%)

PLMR

Palomar

$48.96

0.365 (0.75%)

SNAP

Snap

$19.15

0.03 (0.16%)

SHAK

Shake Shack

$70.29

0.37 (0.53%)

AVGO

Broadcom

$308.22

-0.43 (-0.14%)

ZS

Zscaler

$59.97

0.57 (0.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 04

    Feb

  • 25

    Feb

  • 14

    Apr

  • 16

    Jul

S

Sprint

$5.00

0.2 (4.17%)

13:05
01/21/20
01/21
13:05
01/21/20
13:05
Options
Sprint call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,484.58

4.3 (0.29%)

, GOOGL

Alphabet Class A

$1,483.27

4.15 (0.28%)

12:58
01/21/20
01/21
12:58
01/21/20
12:58
Periodicals
YouTube TV rolls out on PS4 consoles as Vue to shut down soon, Verge says »

Google's (GOOG)…

GOOG

Alphabet

$1,484.58

4.3 (0.29%)

GOOGL

Alphabet Class A

$1,483.27

4.15 (0.28%)

SNE

Sony

$72.44

-0.04 (-0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 03

    Feb

  • 03

    Feb

  • 04

    Feb

  • 10

    Feb

ERIC

Ericsson

$8.89

-0.115 (-1.28%)

12:55
01/21/20
01/21
12:55
01/21/20
12:55
Periodicals
Trump says working with Ericsson, opening up spectrum, Bloomberg reports »

Bloomberg cites comments…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

12:55
01/21/20
01/21
12:55
01/21/20
12:55
General news
FX Action: USD-JPY »

FX Action: USD-JPY…

GOOGL

Alphabet Class A

$1,483.50

4.38 (0.30%)

, GOOG

Alphabet

$1,484.43

4.15 (0.28%)

12:55
01/21/20
01/21
12:55
01/21/20
12:55
Periodicals
Sonos, others testify on big tech anti-competition before Congress, Verge says »

In an antitrust hearing…

GOOGL

Alphabet Class A

$1,483.50

4.38 (0.30%)

GOOG

Alphabet

$1,484.43

4.15 (0.28%)

SONO

Sonos

$15.01

-0.11 (-0.73%)

FB

Facebook

$221.57

-0.44 (-0.20%)

AMZN

Amazon.com

$1,870.50

6.1 (0.33%)

AAPL

Apple

$318.28

-0.38 (-0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 27

    Jan

  • 28

    Jan

  • 29

    Jan

  • 30

    Jan

  • 03

    Feb

  • 03

    Feb

  • 05

    Feb

  • 10

    Feb

12:55
01/21/20
01/21
12:55
01/21/20
12:55
Conference/Events
Senate Impeachment Trial of President Trump »

The Senate Impeachment…

MSFT

Microsoft

$167.73

0.67 (0.40%)

, GOOGL

Alphabet Class A

$1,483.50

4.38 (0.30%)

12:53
01/21/20
01/21
12:53
01/21/20
12:53
On The Fly
Fly Intel: What to watch in IBM's earnings report »

IBM (IBM) is scheduled to…

MSFT

Microsoft

$167.73

0.67 (0.40%)

GOOGL

Alphabet Class A

$1,483.50

4.38 (0.30%)

HPE

HP Enterprise

$14.96

-0.14 (-0.93%)

GOOG

Alphabet

$1,484.43

4.15 (0.28%)

NTAP

NetApp

$61.27

-1.14 (-1.83%)

IBM

IBM

$139.00

0.69 (0.50%)

PSTG

Pure Storage

$18.46

-0.03 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

  • 22

    Jan

  • 29

    Jan

  • 03

    Feb

  • 03

    Feb

  • 10

    Feb

  • 25

    Feb

  • 10

    Mar

  • 11

    Mar

EAF

GrafTech

$12.06

0.05 (0.42%)

12:45
01/21/20
01/21
12:45
01/21/20
12:45
Options
GrafTech call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

AMGN

Amgen

$239.06

-2.47 (-1.02%)

, CYTK

Cytokinetics

$12.19

0.02 (0.16%)

12:36
01/21/20
01/21
12:36
01/21/20
12:36
Recommendations
Amgen, Cytokinetics analyst commentary  »

Piper says Cytokinetics…

AMGN

Amgen

$239.06

-2.47 (-1.02%)

CYTK

Cytokinetics

$12.19

0.02 (0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 30

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.